There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<div class="section">
<a class="named-anchor" id="S1">
<!--
named anchor
-->
</a>
<h5 class="section-title" id="d7160461e112">Objective</h5>
<p id="P1">Most U.S. employers are not required to provide paid sick leave (PSL),
and there is
limited information on the economic return of providing PSL. We estimated potential
benefits to employers of PSL in reducing absenteeism related to the spread of influenza-like
illness (ILI).
</p>
</div><div class="section">
<a class="named-anchor" id="S2">
<!--
named anchor
-->
</a>
<h5 class="section-title" id="d7160461e117">Methods</h5>
<p id="P2">We used nationally representative data and a negative binomial random effects
model
to estimate the impact of PSL in reducing overall absence due to illness or injury.
We used published data to compute the share of ILI from the total days of absence,
ILI transmission rates at workplaces, wages, and other parameters.
</p>
</div><div class="section">
<a class="named-anchor" id="S3">
<!--
named anchor
-->
</a>
<h5 class="section-title" id="d7160461e122">Results</h5>
<p id="P3">Providing PSL could have saved employers $0.63 to $1.88 billion in reduced
ILI-related
absenteeism costs per year during 2007 to 2014 in 2016 dollars.
</p>
</div><div class="section">
<a class="named-anchor" id="S4">
<!--
named anchor
-->
</a>
<h5 class="section-title" id="d7160461e127">Conclusion</h5>
<p id="P4">These findings might help employers consider PSL as an investment rather
than as a
cost without any return.
</p>
</div>
We estimated the possible effects of the next influenza pandemic in the United States and analyzed the economic impact of vaccine-based interventions. Using death rates, hospitalization data, and outpatient visits, we estimated 89,000 to 207,000 deaths; 314,000 to 734,000 hospitalizations; 18 to 42 million outpatient visits; and 20 to 47 million additional illnesses. Patients at high risk (15% of the population) would account for approximately 84% of all deaths. The estimated economic impact would be US$71.3 to $166.5 billion, excluding disruptions to commerce and society. At $21 per vaccinee, we project a net savings to society if persons in all age groups are vaccinated. At $62 per vaccinee and at gross attack rates of 25%, we project net losses if persons not at high risk for complications are vaccinated. Vaccinating 60% of the population would generate the highest economic returns but may not be possible within the time required for vaccine effectiveness, especially if two doses of vaccine are required.
Presenteeism is attending work when ill. This study examined the antecedents and correlates of presenteeism, absenteeism, and productivity loss attributed to presenteeism. Predictors included work context, personal characteristics, and work experiences. Business school graduates employed in a variety of work positions (N = 444) completed a Web-based survey. Presenteeism was positively associated with task significance, task interdependence, ease of replacement, and work to family conflict and negatively associated with neuroticism, equity, job security, internal health locus of control, and the perceived legitimacy of absence. Absenteeism was positively related to task significance, perceived absence legitimacy, and family to work conflict and negatively related to task interdependence and work to family conflict. Those high on neuroticism, the unconscientious, the job-insecure, those who viewed absence as more legitimate, and those experiencing work-family conflict reported more productivity loss. Overall, the results reveal the value of a behavioral approach to presenteeism over and above a strict medical model. (PsycINFO Database Record (c) 2011 APA, all rights reserved).
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.